Scientists seek better blood test for hemophilia breakthroughs
NCT ID NCT07101926
Summary
This study aims to create a reliable laboratory test to measure how well new hemophilia treatments called anti-TFPI antibodies are working. Researchers will test blood samples from 11 adult men with severe hemophilia who are taking these new medications. The goal is to develop a test that can help doctors monitor treatment effectiveness and safety, especially during surgeries or severe bleeding episodes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre de Référence Hémophilie et autres déficits rares en protéine de la coagulationCentre de Traitemendes Hémophiles F. Josso
NOT_YET_RECRUITINGParis, 75015, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Groupement hospitalier Est Hôpital Cardilogique Service d'hémostase clinique
RECRUITINGBron, 69677, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.